funding probability score
total disclosed funding
last round valuation estimate
disclosed funding rounds
latest round
latest funding stage
next round estimate
development stage
number of investors
number of competitors
monthly web visits
twitter followers
United States
HQ address
230 Third Avenue, Waltham, 02451, USA
Avedro is a privately held medical device and pharmaceutical company advancing the science and technology of corneal cross-linking. Today, more than 100,000 eyes around the world have been treated with Avedro’s KXL® System for Accelerated Cross-Linking.

Avedro’s cross-linking systems and family of riboflavin products are not for sale in the US.

There is much more to this profile.
Log in or sign up for free to see the whole thing.

Get free access to these powerful tools:
- Advanced search filters
- Full startup and investor profiles
- Follow startups and investors
- Custom follow-lists
- Startup benchmarking
- Network maps
- Market stats